TRASTUZUMAB EMTANSINE 100 mg (Ujvira) Injection

Uses of TRASTUZUMAB EMTANSINE 100 mg

• Treats HER2-positive breast cancer.
• Used in metastatic breast cancer.
• Used after prior treatment with trastuzumab and taxane therapy.
• Used in residual disease after neoadjuvant therapy in some cases.

Benefits of TRASTUZUMAB EMTANSINE 100 mg

• Targets HER2-positive cancer cells specifically.
• Delivers chemotherapy directly into cancer cells.
• Helps shrink tumors.
• Delays disease progression.
• Improves survival in advanced HER2-positive breast cancer.

How does it work?

Trastuzumab emtansine is an antibody-drug conjugate. Trastuzumab targets the HER2 receptor on cancer cells, and it carries a chemotherapy drug (emtansine) directly into the cancer cell. This targeted delivery kills cancer cells while limiting damage to normal cells.

Precautions

• Given only as an IV infusion under medical supervision.
• Regular monitoring of heart function (risk of cardiotoxicity).
• Monitor liver function and blood counts.
• Inform doctor about heart disease or lung problems.
• Tell your doctor about all medicines you are taking.
• Avoid pregnancy during treatment.
• Report chest pain, shortness of breath, or severe fatigue immediately.

Side Effects

• Fatigue
• Nausea
• Low platelet count
• Headache
• Muscle or joint pain

Trastuzumab Emtansine 100 mg (Ujvira) Injection at competitive wholesale prices from our trusted generic pharmacy

We supply authentic Trastuzumab Emtansine 100 mg Injection, a trusted targeted therapy prescribed for the treatment of HER2-positive breast cancer.

As a global pharmaceutical wholesaler with extensive export expertise, we deliver high‑quality generic medicines to healthcare markets including Colombia, Peru, the Philippines, Venezuela, Panama, Ecuador, Namibia, South Africa, Zimbabwe, Bahrain, Cyprus, Egypt, Iran, Iraq, Israel, Jordan, Palestine, Qatar, Saudi Arabia, the United Arab Emirates, China, Canada, Brazil, Mexico, Russia, Thailand, Malaysia, Singapore, Vietnam, South Korea, Taiwan, Indonesia, the United States, and more.